ZW24886A1 - New ortho-anisamides,process for their preparation and their therapeutic applications - Google Patents

New ortho-anisamides,process for their preparation and their therapeutic applications

Info

Publication number
ZW24886A1
ZW24886A1 ZW248/86A ZW24886A ZW24886A1 ZW 24886 A1 ZW24886 A1 ZW 24886A1 ZW 248/86 A ZW248/86 A ZW 248/86A ZW 24886 A ZW24886 A ZW 24886A ZW 24886 A1 ZW24886 A1 ZW 24886A1
Authority
ZW
Zimbabwe
Prior art keywords
anisamides
preparation
therapeutic applications
new ortho
ortho
Prior art date
Application number
ZW248/86A
Other languages
English (en)
Inventor
Acher Jacques
Schmitt Jean-Paul
Costall Brenda
Monier Jean-Claude
Gardaix-Luthereau Renee
Naylor Robert
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of ZW24886A1 publication Critical patent/ZW24886A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZW248/86A 1985-12-19 1986-12-19 New ortho-anisamides,process for their preparation and their therapeutic applications ZW24886A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8518829A FR2592042B1 (fr) 1985-12-19 1985-12-19 Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques

Publications (1)

Publication Number Publication Date
ZW24886A1 true ZW24886A1 (en) 1987-05-13

Family

ID=9325965

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW248/86A ZW24886A1 (en) 1985-12-19 1986-12-19 New ortho-anisamides,process for their preparation and their therapeutic applications

Country Status (37)

Country Link
US (2) US4835172A (zh)
EP (1) EP0236646B1 (zh)
JP (1) JPS62246553A (zh)
KR (1) KR930004653B1 (zh)
CN (1) CN1018454B (zh)
AR (1) AR242193A1 (zh)
AT (1) ATE57376T1 (zh)
AU (1) AU586057B2 (zh)
CA (2) CA1298301C (zh)
CH (1) CH671396A5 (zh)
CS (1) CS274285B2 (zh)
DD (1) DD260495A5 (zh)
DE (2) DE3674916D1 (zh)
DK (1) DK612886A (zh)
ES (1) ES2036178T3 (zh)
FI (1) FI865190A (zh)
FR (1) FR2592042B1 (zh)
GB (1) GB2184723B (zh)
GR (1) GR3002524T3 (zh)
HU (1) HU196794B (zh)
IE (1) IE59212B1 (zh)
IL (1) IL81010A (zh)
IN (1) IN163130B (zh)
IS (1) IS1448B6 (zh)
MA (1) MA20835A1 (zh)
NO (1) NO168176C (zh)
NZ (1) NZ218675A (zh)
OA (1) OA08564A (zh)
PH (2) PH24365A (zh)
PL (1) PL148408B1 (zh)
PT (1) PT83982B (zh)
SU (1) SU1496632A3 (zh)
TN (1) TNSN86165A1 (zh)
YU (1) YU44796B (zh)
ZA (1) ZA869560B (zh)
ZM (1) ZM10686A1 (zh)
ZW (1) ZW24886A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295350B1 (fr) * 1987-06-17 1992-11-11 Laboratoires DELAGRANGE Application du N-[2-(diethylamino)ethyl]2-methoxy 4-[(1-H 4,5-dihydro-2-imidazolyl) amino]5-chloro benzamide comme anxiolytique et anti-psychotique
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
FR2640507A1 (fr) * 1988-12-20 1990-06-22 Delagrange Laboratoires Application de benzamides substitues comme anxiolytiques et anti-psychotiques
FR2645742A1 (fr) * 1989-04-12 1990-10-19 Delagrange Laboratoires Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US20050140688A1 (en) * 2003-12-29 2005-06-30 Kim Pallister Method and mechanism for programmable filtering of texture map data in 3D graphics subsystems

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR1539104A (fr) * 1967-07-31 1968-09-13 Ile De France Nouveaux benzamides et leur procédé de préparation
US3682968A (en) * 1969-06-25 1972-08-08 Merck & Co Inc Anti-inflammatory salicylic acid derivatives
DE1963193A1 (de) * 1969-12-17 1971-06-24 Bayer Ag N-substituierte 2-Arylimino-oxazolidine,Verfahren zu ihrer Herstellung und ihre Verwendung als Ektoparasiticide
FR2432513A1 (fr) * 1977-10-24 1980-02-29 Merieux Inst Nouveaux derives de la thiazoline et leur application comme medicaments
DE2905883A1 (de) * 1979-02-16 1980-08-28 Boehringer Sohn Ingelheim Radioimmuntest fuer clonidin
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
US4461904A (en) * 1981-11-20 1984-07-24 Alcon Laboratories, Inc. 2-(Trisubstituted phenylimino)-imidazolines
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS6341471A (ja) * 1986-08-08 1988-02-22 Nippon Soda Co Ltd オキサ(チア)ゾリジン誘導体、その製造法及び殺ダニ剤
US4826990A (en) * 1987-09-30 1989-05-02 American Home Products Corporation 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents

Also Published As

Publication number Publication date
CA1299579C (fr) 1992-04-28
FI865190A0 (fi) 1986-12-18
IE863270L (en) 1987-06-19
FR2592042A1 (fr) 1987-06-26
ATE57376T1 (de) 1990-10-15
US4835172A (en) 1989-05-30
CN86108972A (zh) 1987-11-18
GB2184723A (en) 1987-07-01
GB8630143D0 (en) 1987-01-28
PH24469A (en) 1990-07-18
PT83982B (pt) 1989-01-17
NO168176B (no) 1991-10-14
FR2592042B1 (fr) 1988-03-25
PH24365A (en) 1990-06-13
FI865190A (fi) 1987-06-20
ZA869560B (en) 1987-11-25
YU44796B (en) 1991-02-28
IS1448B6 (is) 1991-01-16
KR870006008A (ko) 1987-07-08
EP0236646B1 (fr) 1990-10-10
PT83982A (en) 1987-01-01
DD260495A5 (de) 1988-09-28
DE3643103A1 (de) 1987-06-25
HU196794B (en) 1989-01-30
CS960386A2 (en) 1990-09-12
NO168176C (no) 1992-01-22
SU1496632A3 (ru) 1989-07-23
GB2184723B (en) 1989-12-28
CA1298301C (fr) 1992-03-31
IL81010A (en) 1991-06-30
JPS62246553A (ja) 1987-10-27
NZ218675A (en) 1990-06-26
US4914117A (en) 1990-04-03
CS274285B2 (en) 1991-04-11
EP0236646A1 (fr) 1987-09-16
TNSN86165A1 (fr) 1990-01-01
DE3674916D1 (de) 1990-11-15
IE59212B1 (en) 1994-01-26
PL148408B1 (en) 1989-10-31
CN1018454B (zh) 1992-09-30
NO865148L (no) 1987-06-22
HUT43844A (en) 1987-12-28
AR242193A1 (es) 1993-03-31
YU217986A (en) 1987-12-31
IS3178A7 (is) 1987-06-20
IN163130B (zh) 1988-08-13
GR3002524T3 (en) 1993-01-25
OA08564A (fr) 1988-09-30
MA20835A1 (fr) 1987-07-01
AU586057B2 (en) 1989-06-29
DK612886D0 (da) 1986-12-18
ES2036178T3 (es) 1993-05-16
AU6668786A (en) 1987-06-25
CH671396A5 (zh) 1989-08-31
NO865148D0 (no) 1986-12-18
KR930004653B1 (ko) 1993-06-02
DK612886A (da) 1987-06-20
IL81010A0 (en) 1987-03-31
PL263078A1 (en) 1988-04-14
ZM10686A1 (en) 1987-11-27

Similar Documents

Publication Publication Date Title
DE3572488D1 (en) Dialkoxyridines, process for their preparation, their application and medicaments containing them
EP0187620A3 (en) Pyrrolo-pyrroles, process for their preparation and use
ZA865374B (en) Tertiary hydroxyalkylxanthines,process for their preparation,medicaments containing them and their use
EP0161632A3 (en) Pyrrolo-benzimidazoles, process for their preparation, medicaments containing them and intermediates
EP0230581A3 (en) 3-amino-4,5-dihydroxypiperidines, process for their preparation and their use
ZA854287B (en) Dialkoxypyridines,process for their preparation,their use and medicaments containing them
ZA866529B (en) Azolyl-cyclopropyl-ethanol derivatives,processes for their preparation and their use
ZA86936B (en) 11beta-phenyl-gonanes,their manufacture and pharmaceutical preparations containing them
EP0225433A3 (en) Hydroxyoxaalkyl melamines, process for their preparation and their use
GR862249B (en) Dihydropyridin-2-hydroxyamine process for their preparation and their use as medicaments
ZA869560B (en) New ortho-anisamides,process for their preparation and their therapeutic applications
EP0121081A3 (en) Azolylmethylcycloalkanes, process for their preparation and their therapeutical use
PT81914A (en) Preparation process of 4,4-dialkyl-2-azetidinones
AR241906A1 (es) Un procedimiento para la preparacion de derivados de n-(2-imidazolinil-alquil)-4-amino-benzamida y sus sales farmacologicamente aceptables
DE3660628D1 (en) 1-ethyl- 3-hydroxy-3-phenylpiperidine, process for its preparation and its therapeutical use
EP0211303A3 (en) 2-acyl-5-methyl furans, process for their preparation and their use
DE3661830D1 (en) 2,4-dichlorothiazole derivatives and process for their preparation
DE3561058D1 (en) Hydroxy-thia-alcanes, process for their preparation and their uses
GR861039B (en) Ethanobenzazepines process and intermediates for their preparation and their use as medicaments
DE3662097D1 (en) 4-mercaptobenzonitriles and process for their preparation
DE3661635D1 (en) Ketosultams and process for their preparation
DE3660597D1 (en) Process for the preparation of 5-fluorotoluene-2,4-disulfochloride
GB2185257B (en) 10 beta-alkynyl-4, 9(11)-estradiene derivatives and process for their preparation
EP0232536A3 (en) Spirodiphosphoamidate type compounds and process for their preparation
EP0195738A3 (en) Process for the preparation of n,n -diisopropyl-2-benzothiazyl-sulfenamide